Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| LGVN | LONGEVERON INC | $21.61M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SABS | SAB BIOTHERAPEUTICS INC | $17.44M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KYTX | KYVERNA THERAPEUTICS INC | $100.26M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| IBIO | IBIO INC | $13.22M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PRTA | PROTHENA CORP PUBLIC LTD CO | $408.55M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RNXT | RENOVORX INC | $37.64M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CAPR | CAPRICOR THERAPEUTICS INC | $333.44M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NKTR | NEKTAR THERAPEUTICS | $132.13M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VIGL | VIGIL NEUROSCIENCE INC | $117.61M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GOSS | GOSSAMER BIO INC | $247.67M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TIL | INSTIL BIO INC | $83.14M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| LFWD | LIFEWARD LTD | $15.09M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CTSO | CYTOSORBENTS CORP | $54.38M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RCKT | ROCKET PHARMACEUTICALS INC | $712.69M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RLAY | RELAY THERAPEUTICS INC | $485.19M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CTNM | CONTINEUM THERAPEUTICS INC | $98.57M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| EVAX | EVAXION BIOTECH A | $2.26M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VERV | VERVE THERAPEUTICS INC | $369.39M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GEVO | GEVO INC | $297.12M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TARA | PROTARA THERAPEUTICS INC | $124.23M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SCPH | SCPHARMACEUTICALS INC | $116.66M | N/A | 0.00% | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.